However there are key differences between the two study cohorts; Hoscheidt et al. [16] included only male and females with a parental family of history of AD, whereas our male-only study balanced APOE haplotypes across the groups to minimise the influence of this AD risk factor upon our results. Here, APOE is linked to Alzheimer disease.